Annexin Pharmaceuticals AB (publ)
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2020-02-28 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | VD | Acquisition | 30 000 | 1,28 | SEK | 38 400 | 2020-02-25 |
| 2020-02-28 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | VD | Acquisition | 22 093 | 1,29 | SEK | 28 499,97 | 2020-02-26 |
| 2020-02-28 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | VD | Acquisition | 2 407 | 1,31 | SEK | 3 153,17 | 2020-02-26 |
| 2020-03-02 | Annexin Pharmaceuticals AB (publ) | Susan Suchdev | COO | Subscription | 60 006 | 1,15 | SEK | 69 006,9 | 2020-02-20 |
| 2020-03-05 | Annexin Pharmaceuticals AB (publ) | Henrik Palm | Ekonomi/finanschef | Acquisition | 18 000 | 1,3 | SEK | 23 400 | 2020-03-02 |
| 2020-03-05 | Annexin Pharmaceuticals AB (publ) | Henrik Palm | Ekonomi/finanschef | Acquisition | 2 714 | 1,26 | SEK | 3 419,64 | 2020-03-02 |
| 2020-03-05 | Annexin Pharmaceuticals AB (publ) | Johan Frostegård | Styrelseledamot/suppleant | Subscription | 1 404 972 | 1,15 | SEK | 1 615 717,8 | 2020-02-25 |
| 2020-03-05 | Annexin Pharmaceuticals AB (publ) | Anna Frostegård | Chief Scientific and Medical Officer | Subscription | 1 404 972 | 1,15 | SEK | 1 615 717,8 | 2020-02-25 |
| 2020-03-06 | Annexin Pharmaceuticals AB (publ) | Henrik Palm | Ekonomi/finanschef | Acquisition | 10 000 | 1,3 | SEK | 13 000 | 2020-03-04 |
| 2020-03-06 | Annexin Pharmaceuticals AB (publ) | Henrik Palm | Ekonomi/finanschef | Acquisition | 2 286 | 1,3 | SEK | 2 971,8 | 2020-03-04 |
| 2020-03-06 | Annexin Pharmaceuticals AB (publ) | Henrik Palm | Ekonomi/finanschef | Acquisition | 25 000 | 1,3 | SEK | 32 500 | 2020-03-04 |
| 2020-03-11 | Annexin Pharmaceuticals AB (publ) | Henrik Palm | Ekonomi/finanschef | Acquisition | 10 000 | 1,2 | SEK | 12 000 | 2020-03-05 |
| 2020-07-20 | Annexin Pharmaceuticals AB (publ) | Henrik Palm | Ekonomi/finanschef | Acquisition | 235 758 | 0,4 | SEK | 94 303,2 | 2020-07-16 |
| 2020-07-20 | Annexin Pharmaceuticals AB (publ) | Nils Anders Haegerstrand | VD | Acquisition | 1 250 000 | 0,4 | SEK | 500 000 | 2020-07-16 |
| 2020-12-24 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Chairman of the Board of Directors | Acquisition | 3 000 | 1,78 | SEK | 5 340 | 2020-12-22 |
| 2020-12-24 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Chairman of the Board of Directors | Acquisition | 40 688 | 1,8 | SEK | 73 238,4 | 2020-12-22 |
| 2020-12-24 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Chairman of the Board of Directors | Acquisition | 2 169 | 1,775 | SEK | 3 849,975 | 2020-12-22 |
| 2020-12-24 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Chairman of the Board of Directors | Acquisition | 2 000 | 1,77 | SEK | 3 540 | 2020-12-22 |
| 2020-12-24 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Chairman of the Board of Directors | Acquisition | 29 998 | 1,78 | SEK | 53 396,44 | 2020-12-22 |
| 2020-12-24 | Annexin Pharmaceuticals AB (publ) | Carl-Fredrik Lindner | Chairman of the Board of Directors | Acquisition | 2 145 | 1,795 | SEK | 3 850,275 | 2020-12-22 |